Gemcitabine: A Review of Chemoresistance in Pancreatic Cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Gemcitabine: A Review of Chemoresistance in Pancreatic Cancer

Published:2019 Issue:2 Volume:24 Page:199-212
ISSN:0893-9675
Container-title:Critical Reviews™ in Oncogenesis
language:en
Short-container-title:Crit Rev Oncog

Author:

Sarvepalli Deepika,Rashid Mamoon Ur,Rahman Asad Ur,Ullah Waqas,Hussain Ishtiaq,Hasan Badar,Jehanzeb Sundas,Khan Abdul Kareem,Jain Akriti Gupta,Khetpal Neelam,Ahmad Sarfraz

Publisher

Begell House

Subject

Cancer Research

Link

http://www.dl.begellhouse.com/download/article/6feab0ed42cd738f/CRO-31641 Final.pdf

Cited by 70 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting aberrant amino acid metabolism for pancreatic cancer therapy: Opportunities for nanoparticles;Chemical Engineering Journal;2024-10

2. RNA epigenetic modifications in digestive tract cancers: Friends or foes;Pharmacological Research;2024-08

3. Aronia Berry Extract Modulates MYD88/NF-kB/P-Glycoprotein Axis to Overcome Gemcitabine Resistance in Pancreatic Cancer;Pharmaceuticals;2024-07-09

4. Gemcitabine–Lipid Conjugate and ONC201 Combination Therapy Effectively Treats Orthotopic Pancreatic Tumor-Bearing Mice;ACS Applied Materials & Interfaces;2024-05-30

5. E3 ubiquitin ligase UBR5 promotes gemcitabine resistance in pancreatic cancer by inducing O-GlcNAcylation-mediated EMT via destabilization of OGA;Cell Death & Disease;2024-05-16

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP